Vor Biopharma
VOR
VOR
37 hedge funds and large institutions have $183M invested in Vor Biopharma in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.69% more ownership
Funds ownership: 2.28% → 2.97% (+0.69%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
Holders
37
Holding in Top 10
3
Calls
$361M
Puts
$57.8M
Top Buyers
| 1 | +$24.4M | |
| 2 | +$18.5M | |
| 3 | +$6.42M | |
| 4 |
ACM
Ariose Capital Management
Central, Hong Kong,
Hong Kong
|
+$5.37M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.44M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$768K | |
| 3 | -$687K | |
| 4 |
Jane Street
New York
|
-$464K |
| 5 |
Renaissance Technologies
New York
|
-$429K |
